Isomannide derivatives as new class of inhibitors for human kallikrein 7.

[1]  M. Blaber,et al.  Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7. , 2011, Bioorganic & medicinal chemistry letters.

[2]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[3]  A. Longatto-Filho,et al.  Analysis of human kallikrein 7 expression as a potential biomarker in cervical neoplasia , 2010, International journal of cancer.

[4]  A. Tanuri,et al.  Pseudo-peptides derived from isomannide: inhibitors of serine proteases , 2010, Amino Acids.

[5]  R. Gallo,et al.  The molecular pathology of rosacea. , 2009, Journal of dermatological science.

[6]  R. Dauskardt,et al.  Effect of corneodesmosome degradation on the intercellular delamination of human stratum corneum. , 2008, The Journal of investigative dermatology.

[7]  Christine Humblet,et al.  Investigation of MM-PBSA Rescoring of Docking Poses , 2008, J. Chem. Inf. Model..

[8]  I. S. Fernández,et al.  Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6). , 2008, Journal of molecular biology.

[9]  E. Diamandis,et al.  Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy , 2007, The British journal of dermatology.

[10]  A. Krüger,et al.  Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells , 2006, Biological chemistry.

[11]  B. Kuhn,et al.  Validation and use of the MM-PBSA approach for drug discovery. , 2005, Journal of medicinal chemistry.

[12]  M. G. Albuquerque,et al.  N-t-Boc-amino acid esters of isomannide Potential inhibitors of serine proteases , 2004, Amino Acids.

[13]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[14]  W. Lubell,et al.  Efficient synthesis of enantiopure pyrrolizidinone amino acid. , 2003, The Journal of organic chemistry.

[15]  T. Kercher,et al.  Efficient, stereoselective synthesis of oxazolo[3,2-a]pyrazin-5-ones: novel bicyclic lactam scaffolds from the bicyclocondensation of 3-aza-1,5-ketoacids and amino alcohols. , 2003, Organic letters.

[16]  K. Saijoh,et al.  Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. , 2002, The Journal of investigative dermatology.

[17]  J. Clements,et al.  Tissue-specific Expression Patterns and Fine Mapping of the Human Kallikrein (KLK) Locus on Proximal 19q13.4* , 2000, The Journal of Biological Chemistry.

[18]  P. Nelson,et al.  New nomenclature for the human tissue kallikrein gene family. , 2000, Clinical chemistry.

[19]  K. Wang,et al.  Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. , 2000, Gene.

[20]  M. Brattsand,et al.  Molecular cloning and tissue expression of the murine analog to human stratum corneum chymotryptic enzyme. , 1999, The Journal of investigative dermatology.

[21]  T. Egelrud,et al.  Stratum corneum chymotryptic enzyme in psoriasis , 1999, Archives of Dermatological Research.

[22]  A. Ito,et al.  Internally quenched fluorogenic protease substrates: Solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzoyl/dinitrophenyl groups as donor-acceptor pairs , 1995, Letters in Peptide Science.

[23]  M. Brattsand,et al.  A proteolytic cascade of kallikreins in the stratum corneum. , 2005, The Journal of investigative dermatology.